Barclays’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
40,193
+1,949
| +5% | +$10.6K | ﹤0.01% | 3474 |
|
|
2025
Q1 | $106K | Buy |
38,244
+3,408
| +10% | +$9.45K | ﹤0.01% | 3666 |
|
|
2024
Q4 | $118K | Buy |
34,836
+11,890
| +52% | +$40.3K | ﹤0.01% | 3759 |
|
|
2024
Q3 | $67K | Buy |
+22,946
| New | +$67K | ﹤0.01% | 3844 |
|
|
2024
Q2 | – | Sell |
-12,289
| Closed | -$37K | – | 4209 |
|
|
2024
Q1 | $37K | Sell |
12,289
-80,928
| -87% | -$244K | ﹤0.01% | 3876 |
|
|
2023
Q4 | $393K | Sell |
93,217
-4,429
| -5% | -$18.7K | ﹤0.01% | 3137 |
|
|
2023
Q3 | $666K | Sell |
97,646
-19,296
| -17% | -$132K | ﹤0.01% | 2365 |
|
|
2023
Q2 | $1.22M | Buy |
116,942
+16,782
| +17% | +$175K | ﹤0.01% | 2029 |
|
|
2023
Q1 | $698K | Sell |
100,160
-25,090
| -20% | -$175K | ﹤0.01% | 2390 |
|
|
2022
Q4 | $755K | Buy |
125,250
+54,195
| +76% | +$327K | ﹤0.01% | 2330 |
|
|
2022
Q3 | $561K | Sell |
71,055
-32,951
| -32% | -$260K | ﹤0.01% | 2516 |
|
|
2022
Q2 | $1.42M | Buy |
104,006
+22,161
| +27% | +$302K | ﹤0.01% | 1811 |
|
|
2022
Q1 | $1.61M | Buy |
+81,845
| New | +$1.61M | ﹤0.01% | 1946 |
|